Richard Layese

3.0k total citations
36 papers, 410 citations indexed

About

Richard Layese is a scholar working on Epidemiology, Hepatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Richard Layese has authored 36 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 16 papers in Hepatology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Richard Layese's work include Liver Disease Diagnosis and Treatment (13 papers), Hepatitis C virus research (9 papers) and Liver Disease and Transplantation (8 papers). Richard Layese is often cited by papers focused on Liver Disease Diagnosis and Treatment (13 papers), Hepatitis C virus research (9 papers) and Liver Disease and Transplantation (8 papers). Richard Layese collaborates with scholars based in France, Switzerland and Belgium. Richard Layese's co-authors include Pierre Nahon, Carole Cagnot, Olivier Séror, Étienne Audureau, Isabelle Durand‐Zaleski, Franck Le Duff, Julie Bulsei, Charlotte Costentin, Philippe Robert and Karine Chevreul and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Hepatology.

In The Last Decade

Richard Layese

32 papers receiving 404 citations

Peers

Richard Layese
Alev Bakır Türkiye
Sun Jae Park South Korea
Meike Dirks Germany
W.L. Ng Australia
Alena M. Pfeil Switzerland
Alev Bakır Türkiye
Richard Layese
Citations per year, relative to Richard Layese Richard Layese (= 1×) peers Alev Bakır

Countries citing papers authored by Richard Layese

Since Specialization
Citations

This map shows the geographic impact of Richard Layese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Layese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Layese more than expected).

Fields of papers citing papers by Richard Layese

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Layese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Layese. The network helps show where Richard Layese may publish in the future.

Co-authorship network of co-authors of Richard Layese

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Layese. A scholar is included among the top collaborators of Richard Layese based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Layese. Richard Layese is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Durrmeyer, Xavier, Laurent Storme, Thierry Debillon, et al.. (2024). Respiratory outcomes and survival after unplanned extubation in the NICU: a prospective cohort study from the SEPREVEN trial. Archives of Disease in Childhood Fetal & Neonatal. 109(6). 586–593. 1 indexed citations
2.
Dubois, Sydney, Richard Layese, Nicolas Limal, et al.. (2024). When is the use of intravenous immunoglobulin appropriate in immune thrombocytopenia?. British Journal of Haematology. 205(6). 2425–2431.
3.
Roulot, Dominique, Ségolène Brichler, Richard Layese, et al.. (2024). High Diagnostic Value of Transient Elastography for Advanced Fibrosis and Cirrhosis in Patients With Chronic Hepatitis Delta. Clinical Gastroenterology and Hepatology. 23(6). 978–986.e4. 2 indexed citations
4.
Nault, Jean‐Charles, Richard Layese, Lorraine Blaise, et al.. (2024). Prolonged survival in women with hepatocellular carcinoma: A French observational study. Clinics and Research in Hepatology and Gastroenterology. 48(10). 102498–102498. 1 indexed citations
5.
Cohen, Robert, Valérie Biran, Fabrice Decobert, et al.. (2023). Determinants of morbidity and mortality related to health care-associated primary bloodstream infections in neonatal intensive care units: a prospective cohort study from the SEPREVEN trial. Frontiers in Pediatrics. 11. 1170863–1170863. 4 indexed citations
6.
Oubaya, Nadia, Slim Fourati, Sébastien Beaune, et al.. (2023). Prognosis of hospitalised adult patients with respiratory syncytial virus infection: a multicentre retrospective cohort study. Clinical Microbiology and Infection. 29(7). 943.e1–943.e8. 24 indexed citations
7.
Aparicio, Thomas, Richard Layese, F. Hémery, et al.. (2023). The 10-month mortality rate among older patients treated for digestive system cancer during the first wave of the COVID-19 pandemic: The CADIGCOVAGE multicentre cohort study. Journal of Geriatric Oncology. 14(2). 101443–101443. 2 indexed citations
9.
Youssov, Katia, Étienne Audureau, Richard Layese, et al.. (2022). The burden of Huntington's disease: A prospective longitudinal study of patient/caregiver pairs. Parkinsonism & Related Disorders. 103. 77–84. 8 indexed citations
10.
Layese, Richard, et al.. (2022). Paradoxical reactions and biologic agents: a French cohort study of 9303 patients. British Journal of Dermatology. 187(5). 676–683. 9 indexed citations
11.
Nahon, Pierre, Richard Layese, Carole Cagnot, et al.. (2021). HCV Eradication in Primary or Secondary Prevention Optimizes Hepatocellular Carcinoma Curative Management. Cancer Prevention Research. 14(5). 581–592. 1 indexed citations
12.
Kempf, Emmanuelle, Guillaume Lamé, Richard Layese, et al.. (2021). New cancer cases at the time of SARS-Cov2 pandemic and related public health policies: A persistent and concerning decrease long after the end of the national lockdown. European Journal of Cancer. 150. 260–267. 31 indexed citations
13.
Urbina, Tomas, Florence Canouï‐Poitrine, Camille Hua, et al.. (2021). Long-term quality of life in necrotizing soft-tissue infection survivors: a monocentric prospective cohort study. Annals of Intensive Care. 11(1). 102–102. 17 indexed citations
14.
Zarski, Jean‐Pierre, Sandra David‐Tchouda, Candice Trocmé, et al.. (2019). Non-invasive fibrosis tests to predict complications in compensated post-hepatitis C cirrhosis. Clinics and Research in Hepatology and Gastroenterology. 44(4). 524–531. 6 indexed citations
15.
Gelu‐Siméon, Moana, M. Lewin, Maria A. Ostos, et al.. (2018). Prognostic factors of survival in HIV/HCV co‐infected patients with hepatocellular carcinoma: The CARCINOVIC Cohort. Liver International. 39(1). 136–146. 11 indexed citations
16.
Bastard, Jean‐Philippe, Soraya Fellahi, Étienne Audureau, et al.. (2018). Elevated adiponectin and sTNFRII serum levels can predict progression to hepatocellular carcinoma in patients with compensated HCV1 cirrhosis. European Cytokine Network. 29(3). 112–120. 7 indexed citations
17.
Allaire, Manon, Richard Layese, Erwan Guyot, et al.. (2018). Virologic control and severity of liver disease determine survival after radiofrequency ablation of hepatocellular carcinoma on cirrhosis. Digestive and Liver Disease. 51(1). 86–94. 14 indexed citations
19.
Wendum, Dominique, Richard Layese, Nathalie Ganne‐Carrié, et al.. (2018). Influence of Progenitor‐Derived Regeneration Markers on Hepatitis C Virus–Related Cirrhosis Outcome (ANRS CO12 CirVir Cohort). Hepatology. 68(4). 1534–1548. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026